Herbal products are believed to be safe as they are naturally occurring, however, this is a misconception. Currently, there are many herbal products which are not manufactured under the Good Manufacturing Practice (GMP) guidelines and hence the quality of the product is not controlled. Quality can be assessed by evaluation of data on levels of either active constituent(s) or chemical markers indicative of origin of plant material. Assessment of published data on levels of quality of herbal medicinal products revealed that only a percentage of the total number of products investigated were found to contain the levels of markers as stated on the label, and others had widely varying levels of constituents. Thus few products complied with acceptable quality control standards. Herbal products are increasingly self-prescribed for the treatment of minor ailments. Patients relying on herbal products for therapeutic effects may expose themselves to either low doses of active constituents causing insufficient effects or alternatively take higher levels than expected, with the increased risk of toxicity or adverse effects, or be affected by the inadvertent inclusion of unexpected components with associated potential health risks.
The use of herbal products in the UK and elsewhere has increasingly grown over the past 30 years. The most common users have been found to be Caucasians and females, but there is no major difference between the ages of users [1] . Literature suggests that people use herbal products because they believe that they are 'safe', as they are naturally occurring. They are claimed to maintain general health; are used to treat minor and self-limiting conditions; are often taken due to dissatisfaction with conventional medicines, and a desire for greater control over the health care situation; and/or taken by patients attracted either to holistic or natural therapies [2] . Herbal products are now readily available as OTC products in pharmacies, supermarkets and health food stores worldwide. The most common formulations which can be bought include both solid (tablets, capsules, lozenges) and liquid (tinctures, syrups, plant juices) products. Other formulations include spirits, which can be inhaled in water, or alcohol and oils, which can be used either externally or internally [3] . Currently, a large number of herbal medicinal products are available unlicensed on the market, for which no quality standards are applicable. Poor quality products are, therefore, legally available to consumers with no legally required GMP certification.
A new European Union (EU) directive for the regulation of herbal products was introduced in October 2005. It is a regulatory framework for unlicensed herbal products called the Traditional Herbal Medicinal Product Directive (THMPD). The aim of the THMPD is to allow medicinal licensing of these products. Therefore, manufacturers of herbal products are given the opportunity to register them as medicines under the Traditional Herbal Medicine Registration Scheme (THMRS).
The THMRS was developed to protect consumers. However, it can also be advantageous to manufacturers as it will allow them to make medicinal claims on the label and provide dosage indications based on their traditional use. Any products that were legally marketed in the UK before 30 th April 2004 can continue to be sold as unlicensed herbal products until 30 th April 2011. This is the transitional period for manufacturers to make all the necessary changes so that their products can comply with the new proposed requirements. Products which are still available on the market after 30 th April 2011 can be sold until the stock runs out, provided they were placed on the market legally. Any new herbal products since 30 th April 2004 which are available over the counter (OTC) will be required to either have a traditional herbal medicine registration or a full manufacturing authorization [4] .
Under the new regulations, manufacturers will be required to develop a dossier regarding the quality and safety of the products. This will be based on their traditional use and demonstrate that the manufacturing process is in accordance with the good manufacturing practice guidelines (GMP). The manufacturers also have to show that the herbal remedy has been traditionally used for either thirty years in the EU or at least fifteen years in the As a result of the THMPD, the quality standards of herbal medicines will be improved. Manufacturers will be required to operate to GMP standards, thereby ensuring that the quality of the product is checked and assured at all stages from cultivation to the finished product. The safety of these products will also be improved as pharmacovigilance requirements will also apply to these products [4] .
Quality control: It is believed that because herbal products are naturally occurring and can be purchased without a prescription they are 'safe', but this is a misconception. They are not required either to have specified amounts of active constituents or undergo clinical trials to obtain safety and efficacy data. Unlike conventional medicines, unlicensed herbal products are not required to be manufactured in accordance with GMP guidelines. Therefore, there is no legal requirement for the product to contain what is stated on the label [2] . Some products contain specified amounts of herbal constituents while others contain an unspecified amount. The amount of herbal constituents can be variable because the product may be produced from different parts of the plants, and each plant part may produce either the same or different pharmacologically active compounds, which may either be therapeutic, inactive, or toxic.
Some manufacturers try to standardise the manufacturing process by specifying the product content, for example standardized extracts of Ginkgo biloba contain 22-27% of the active constituent. This reduces the risk of toxic metabolites and batch-to-batch variations. However, this is not possible for all herbal products, for example St John's Wort (Hypericum perforatum), which may contain a number of active constituents, and consequently it is difficult to determine the main active constituent [2] .
Although many herbal products are not currently regulated to ensure they are of good quality, some manufacturers standardize their products to prevent variability. Nonetheless, products which have poor quality have many disadvantages and risks which can greatly affect the consumer. When the quality of the herbal product is poor, the quantity of the active constituents is often unknown. Therefore, when consumers use these products and follow the dose stated on the label the effects they experience can range from no effect to serious adverse drug reactions (ADRs). Often, little effect is experienced if the dose taken contains a lower amount of active constituent than that stated on the label. However, this is not always the case. In 2003, Kava (Piper methysticum) was prohibited in the UK due to hepatoxicity. It has been proven that Kava causes hepatoxicity, but the dose at which ADRs occur is not definitive. In many cases, the exact toxic dose could not be determined due to factors such as the quality of the products, concomitant use with other drugs, diet, and lifestyle [2] .
Herbal products can be either accidentally or intentionally contaminated (adulteration) with alternative material(s). Contaminants can include heavy metals, herbicides, insects, botanical substitution, pesticides, micro-organisms and conventional medicines [2] . In China, Aristolochia fangchi and Stephania tetrandra are commonly named 'Fang Ji'. In the 1990s a weight loss drug was adulterated with Aristolochia fangchi instead of Stephania tetrandra, due to confusion between the Chinese names. This led to a small number of deaths, and some of the patients required dialysis or kidney transplantation [5] .
Aims and objectives:
For conventional medicines, the European Pharmacopeia (Ph.Eur.) states that the content of the active substance must be within 95-105% of the label claim, and this standard should be applied equally to herbal products to assess their quality. Table 1 outlines the wide range of outcomes from published investigations on the quality of herbal products, and shows which analytical methods were used to determine the quality, how many products were tested and out of which, the number of products which had a content level which was 95-105% of the label claim, where available. In products which were analyzed for two different markers, both were required to have contents within 95-105% of the label claim.
Discussion
Aloe vera: Garrard et al investigated the quality of commercially available Aloe vera products, and found discrepancies in listed label contents and dosage with respect to standards [6] .
A very inexpensive and simple, but reproducible, colorimetric method was devised for the assay of glucomannan content. This method did not suffer from interference from non-aloe polysaccharides, and the linearity was from 0.9-72.7 mg/L. Detection of glucomannan as the sole polysaccharide allows for clear quantification of glucomannan alone, and does not register levels of other polysaccharides which have frequently been reported as adulterants of Aloe vera [7] . HPLC-UV Parthenolide 10 7
The parthenolide content ranged from 0.14-0.74%. Some products did not contain the minimum parthenolide content of 0.2% (US standard). Feverfew/ Canada [20] HPLC-UV Parthenolide 46 1 Thirty products had specified a content claim and fifteen were standardized to contain a minimum 0.2% parthenolide. Majority of the products contained a lower content of parthenolide and some products contained a higher content. Feverfew/ US [21] HPLC-UV Parthenolide 5 0 All the products were standardized to contain 0.2-1.2% parthenolide, but the actual parthenolide content was 0-0.309%. Two products contained the minimum parthenolide content of 0.2%. Garlic/ US [22] HPLC Allicin 0-3600g/g in powder tablets Dialkenylsulfides 220-7340 g/g in steam distilled products. Garlic/ US [6] NA NA 143 111 Seventy products were consistent in ingredients and dosage with the 736 Natural Product Communications Vol. 6 (5) 2011
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Commission E standard. Forty products were consistent in ingredient, but not in dosage with the reference. Thirty-two products were inconsistent in dosage and ingredients. Ginger/ US [23] HPLC Gingerols 6-gingerol 0-9.4 mg/g 6-shogaol 0.2-2.2 mg/g 9-gingerol 0-0.7 mg/g 10-gingerol 0-1.4 mg/g Ginkgo biloba/ Multinational [24] Fluorophotometric TLC
Ginkgo terpenes
Widely differing terpene levels in 10 Chinese tablet products, and widely differing levels between batches of the same product. Relatively high consistency between different products and batches of German and French products. Ginkgo biloba/ US [25] HPLC-UV HPLC-ELSD Flavonol glycosides, terpene lactones 9 0
The terpene lactone content was higher than the label claim in all the products. Ginkgo biloba/ US [26] HPLC-UV Flavonol glycosides and terpene lactones 27 3
Most of the products were standardized to contain 24% flavonol glycosides and 6% terpene lactones. Majority of the products contained more than the specified content on the label. Ginkgo biloba / Canada [27] HPLC-UV HPLC-electrospray MS Flavonol glycosides and terpene lactones 10 8
All the products were standardized to contain 24% flavonol glycosides and 6% terpene lactones. One of products was adulterated to contain up to six times more flavonol glycoside content and one product was thought to be fraudulent as there were neither flavonol glycosides nor terpene lactones present. Ginkgo biloba/ South Africa [28] HPLC which are markers of poor quality products. This method identified and quantified fifteen anthocyanins and five anthocyanidins and revealed that only 15% of the products tested had the same level of anthocyanins as the test materials shown to be effective in clinical trials. The method also showed a distinct and marked difference between samples with common origins [9] .
Echinacea: Cichoric acid and echinacoside are two substances found in Echinacea species, of which there are three, E. purpurea, E. angustifolia and E. pallida. Cichoric acid is only found in E. purpurea, but echinacoside is found in both E. angustifolia and E. pallid. However, these two substances have been demonstrated to have different clinical efficacies [46] . Gilroy et al. used densitometric TLC to identify the Echinacea species and carry out analysis of echinacoside and cichoric acid levels, and found that six out of 59 products contained no measurable constituents. Contents were found to be consistent with label claims in 52% of the samples [11] .
As different species of Echinacea can have different effects, Gilroy et al. [11] and Krochmal et al. [13] investigated which products contained the species stated on the label. Krochmal et al. used HPLC to identify and quantify the echinacoside and cichoric acid contents. HPLC-UV is an appropriate method to separate the different Echinacea compounds and quantify echinacoside and cichoric acid using UV, as both of these compounds have UV absorbing chromophores.
Molgaard et al. used an HPLC method to establish the quality of Danish grown material and found it to be of high quality. The method was also used to assay commercially available products. In addition to tinctures and extracts, six capsule formulations were assayed and found to contain widely varying levels of active constituents; three had virtually none [12] .
Foster et al. also used an HPLC assay and found some commercial products completely lacking in marker compounds [14] .
Ephedra: Two surveys of Ephedra (Ephedra spp.) supplements from the US showed wide variation in contents of ephedrine analogues, both between products [16] and with samples from the same source [17] . The latter study noted improved conformity of products to standards compared with earlier reports. Two analyses of commercial formulations using HPLC quantified levels of ephedrine, pseudoephedrine, methylephedrine, norephedrine, and norpseudoephedrine. Variability in the levels of these compounds was reported [15, 16] .
A LC-tandem mass spectrometric method was developed by Trujillo and Sorenson to determine levels of six major ephedrine derivatives. The method was evaluated by ten international collaborating laboratories, and five Ephedra products compared using the standard method [47] .
Feverfew: Parthenolide, the main marker compound in feverfew (Tanacetum parthenium) products, is responsible for most of the therapeutic effects exhibited by feverfew and the effects exhibited are dose dependant. In France, feverfew products are required to have a minimum of 0.1% parthenolide, and in the UK, US and Canada, a minimum content of 0.2% parthenolide [21] .
Parthenolide is a sesquiterpene lactone which lacks strong UV chromophores, but UV detection is commonly used [48] . Most researchers used HPLC-UV for qualitative and quantitative analysis of the chemical constituents. Feverfew products contain many constituents, and a number are still unidentified [18] . In addition to HPLC-UV, Heptinstall et al. used proton nuclear magnetic resonance ( 1 H NMR) spectroscopy for quantification of parthenolide, and revealed that although there were highly variable levels of this compound in twenty-two solid formulated products, the highest levels were to be found in home grown plant material. Later, Nelson et al. again found widely varying parthenolide levels in formulated products, from 0.14-0.74% over the twenty-one products investigated [19] . The same technique was later employed for Canadian products and variability of contents was again recorded [20] . Jin et al. also used microscopic and macroscopic examinations to determine raw material product quality, and also extensively evaluated the formulation-relevant physical properties of commercial extracts, and found wide variations in samples of different origin [21] .
Garlic: There are multiple constituents present in garlic (Allium sativum). The amount of garlic present in a product can vary significantly depending on the manufacturing and handling processes [49] .
Lawson et al. separated the dialkenyl thiosufinates of garlic, including allicin, and their degradation products, using HPLC. Resolution was achieved for nine dialkenyl thiosulfinates, the vinyldithiins and the ajoenes. The method was used to quantify components of a number of dry garlic tablets, garlic powders, steam distilled garlic oils and oil macerated garlic products. There was seen to be a four-fold difference in levels of components in the last product group, but up to 33-fold variation in steam distilled oils [22] .
Ginger: Swertner et al. identified and quantified the four major ginger (Zingiber officinalis) constituents of capsules and beverages, using C-8 reversed phase HPLC. The 6-gingerol degradation product, 6-shogaol, was resolved from the three other compounds, and this product can be used to determine the level of 6-gingerol decomposition [23, 50] .
Gingko biloba: Flavonol glycoside and terpene lactones are the two main active constituents present in Ginkgo biloba extracts. The World Health Organisation (WHO) and the German Commission E has produced a monograph which states that G. biloba products should be standardized to contain 22-27% flavonoids and 5-7% terpene lactones [51] .
Using HPLC, Sloley et al. investigated the terpene lactone and total flavonol glycoside contents; they compared the total flavonol glycoside content with the content of intact flavonol glycosides. The intact flavonol glycosides are naturally present in the extracts. The intact flavonol glycoside and total flavonol glycoside contents should be equivalent. However, if the total flavonol glycoside content is higher, this indicates adulteration with either flavonol or flavonol glycosides, and rutin adulteration was suggested in some products [27] .
Most authors used HPLC for qualitative analysis but the choice of detector depended on whether flavonol glycosides or terpene lactones were being detected. The terpene lactones are comprised of mainly five ginkgolides, but there are many different flavonol glycosides in G. biloba.
UV detectors have been used to quantify the terpene lactones, but these are poor chromophores. In this case, either gas chromatography-mass spectrometry (GC-MS) or HLPC-MS give a better detection as the methods are simple, sensitive and selective to quantify the terpene lactone content. HPLC-Evaporative Light Scattering Detection (ELSD) can also be used as an alternative as it is relatively inexpensive, sensitive, and able to quantify the terpene lactone content [27] . One author used HPLC coupled with an electrospray MS detector to analyze terpene lactones which has good sensitivity, accuracy, and is able to detect polar constituents. However, UV detectors are suitable for detecting the quantity of flavonol glycosides as they have strong UV chromophores. Camponovo et al. employed ELSD and thermospray MS in their investigations of Ginkgo. Resolution and quantification of bilobalide and four ginkgolides was carried out on raw material and three formulated products; bilobalide was the major component in all samples, and the new techniques produced similar results to GC using FID [53] . ELSD of components resolved on HPLC was later used by Dubber and Kanfer in their survey of the composition of five commercial products [28] . Li and Fitzloff again used HPLC-ELSD in their survey of nine
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Kressman used HPLC analysis for quantification of constituents in twenty-seven tablet and capsule formulations; flavonol glycoside levels ranged from 24-36%, while terpene lactones ranged from 4-11% Ginkgolic acids exhibited extreme variability, from <500ppm to 90,000ppm [26] . Fluorophotometric thin layer chromatography (TLC) with thermochemical derivatization has also been employed in a survey of products [24] . Both Chinese and international products were evaluated, terpene lactones again showing wide variability.
A UK survey of antioxidant activity of a range of commercially available products showed wide variability, again even between products from the same manufacturer [52] . This indicates that assays for marker chemicals may still not give an indication of the actual activities of herbal medicinal products.
Ginseng:
There are many different types of ginseng (Panax ginseng) products available on the market. Korean and Asian products are prepared from the Panax genus. Panax ginseng contains a number of components, which include ginsenosides. There are many different types of ginsenosides which all have different pharmacological activity. The ratio of ginsenosides varies in different Panax species. Siberian Ginseng products are commonly prepared from the dry roots of Eleutherococcus senticosus. Eleutherosides are specific constituents of E. senticosus; there are seven different eleutherosides, which are used to detect the presence of E. senticosus in Ginseng products [46] .
Liberti and der Marderosian first used densitometric TLC to analyze the ginsengoside content of twenty-four commercial products. Individual total concentrations of active constituents were found to vary considerably. There was widespread product variability, and concentration of ginsenosides ranged from fifteen-and thirty-six-fold in capsules and liquid formulations respectively, while concentrations of eleutherosides varied by forty-three-and two hundred-fold in capsules and liquids respectively [29] . Cui et al. evaluated fifty commercial products sold in eleven countries. In forty-four of these products, ginsenoside concentration varied from 1.9-9.0% and six products did not contain any ginsengosides [30] .
Cui analyzed 48 different ginseng products using GC and GC-MS. Fourteen of the highest quality products contained 1.9-8.1 % of ginsenosides, while ginseng extracts contained from 4.9-13.3 % of markers. A number of degradation products were also identified [31] .
Later, Cui et al. investigated the ginsenosides content of
Panax ginseng products. Although there were no label claims for levels of markers in most of the eighteen products, ginsengosides were detected in all samples. Only one in four of the products with content claims contained sufficient marker levels [33] . Krochmal et al. investigated the total ginsenoside content of nine Ginseng products [13] . Harkey et al. investigated Ginseng products to determine if they were from the Panax or Eleutherococcus genera by determining the presence of either ginsenosides or eleutherosides in each product. [34] HPLC-UV and liquid chromatography (LC)-MS-MS were also used to identify and quantify ginsenosides and eleutherosides. Negative ion electrospray LC-MS-MS is a suitable method to confirm the identities of ginsenosides and eleutherosides as they are polar compounds. The ginsenosides were quantified using UV wavelengths of 203 and 210 nm, and the eleutherosides at 220nm. Kava: Micellar electrokinetic chromatography was employed to carry out qualitative and quantitative analysis of kavalactones by Lechtenberg et al., and this development superseded previous HPLC assays used to separate the lactones; six were resolved and identified [35] . More recently, Bilia et al. developed a method using 600 MHz 1 H NMR spectroscopy for fingerprinting the lactones present in the commercial herbal drug, and the method was able to quantify the components without prior separation [54] . An HPLC assay was used to separate and estimate levels of methysticin, dihydromethysticin, kawain, dihydrokawain, yangonin and desmethoxyyangonin, and the levels of total kavalactones were calculated [13] .
Liquorice: Sabbioni et al. used isocratic HPLC to separate and quantify glycyrrizin and glycyrrhetinic acid in commercial liquorice (Glycyrrhiza glabra) products, and this method was also suitable for herbal products [37] . Previously, Sun et al. had used capillary electrophoresis to produce fingerprints of liquorice tablets. The major components separated, identified and quantified were glycyrrhizic acid and glycyrrhetinic acid [36] .
Noni: C-18 HPLC was used by Potterat et al. to separate Noni (Morinda citrifolia) marker chemicals identified by HPTLC [38] . Gradient elution was required to separate the components and electrospray ionization (ESI)-MS was used for detection and quantification, with limits of quantification going down to 1.0 ng or lower.
St John's Wort: St John's Wort contains a variety of constituents, the major ones being hyperforin, pseudohypericin and hypericin, which all have different pharmacological activities. The amount of these markers can vary depending on the plant part used in the product. The total hypericin content includes pseudohypericin and hypericin. The US Pharmacopeia (USP) states that the 740 Natural Product Communications Vol. 6 (5) 2011
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Quantitative UV spectroscopy was an early technique used for St John's Wort analysis, and was employed by Constantine and Karshesy for eight tablet and capsule formulations. Hypericin levels ranged from 47-165% of label claims [39] .
HPLC is a suitable method for the separation and identification of hypericin, hyperforin and pseudohypericin. Hyperforin is polar and hypericin and pseudohypericin are non-polar, and HPLC can successfully separate these compounds based on their polarity. UV detection can accurately estimate the hypericin, pseudohypericin and hyperforin contents.
Using HPLC, Glisson et al. analyzed thirteen products obtained from health food stores to determine the pseudohypericin and hypericin contents, which were combined to give the total hypericin content [42] .
Ganzera et al. used HPLC to separate nine flavonoids, naphthodianthrones, and hyperforin in twelve commercial products. The last marker was absent from one product, but ranged from 0.04 mg/ to 1.30 mg/100 mg in the remaining ones [40] .
Saw palmetto: Krochmal et al. separated and quantified the free fatty acids of saw palmetto (Serenoa repens) by GC of the silylated derivatives. Silylation was via BSTFA (99%): TMCS (1%), which was selected as it would not hydrolyze or transesterify the fatty acids incorporated as formulation aids [13] .
Valerian: Valerian (Valeriana officinalis) contains active constituents that include an essential oil, valepotriates, and a non-essential oil, valerenic acid.
Both of these constituents have different pharmacological activities. The content of valepotriates and valerenic acid can vary depending on the plant used, particularly in valerian rhizomes and roots. Valepotriates are highly unstable and not often added to products in high concentrations due to their degradation when taken orally [46] . The USP states that powdered valerian products should not contain less than 0.3% of volatile oil and 0.04% valerenic acid [45] .
Valerenic acid is a non-volatile, polar compound and valepotriates have low volatility, but are non-polar and thermally unstable. HPLC is useful for separating these compounds due to the difference in their polarity, ease of use and rapidity. TLC could be used for the separation of valerenic acid as it is cheap and easy to use. It cannot be used for valepotriates as it can cause partial decomposition [55] . TLC can provide qualitative information about the possible identification of valerenic acid. HPLC with UV detection was used to compare marker levels in thirty-one commercial products. Valerenic acid was estimated in the products, but valepotriates could not be detected in any of the solid dosage forms analyzed [43] . HPLC was also used to compare samples made by a single manufacturer and valerenic acid levels were found to vary widely between capsules in the same batch [44] . A further survey, using both TLC and HPLC, quantified valerenic acid in six products and noted wide variability [45] .
From the published studies, there is often no standardized marker to assess the quality of a particular herbal product. However, most of the markers which were chosen were recommended in the USP and Ph. Eur. for identifying and quantifying products. The choice of the marker varied among the reviews depending on the focus of the report; authors either investigated the active constituent(s) or the species of plant present in the product. In each of the studies, the markers selected were considered appropriate to determine the quality of the products.
Many studies used active constituents as a marker of quality because many herbal products produce dose dependant effects. If products contain high levels of active constituents they can cause toxicity and unwanted adverse reactions.
On the other hand, low levels of active constituents can have no therapeutic effect. From Table 1 it can be seen that a number of products were found to contain acceptable levels of marker chemicals.
Factors affecting quality
All herbal products can have batch-to-batch and manufacturer-to-manufacturer variations due to factors such as weather, storage, time of harvest and the manufacturing process. These factors can alter the amount of active constituents present in the herbal material.
A number of studies have revealed that manufacturers have used different plant parts, with consequent variable levels of markers. Processing techniques such as drying of extracts also has an impact on the end product; freeze dryextracts have been shown to have far greater solubility than powdered plant material, hence have a direct effect on bioavailability. Published surveys show that there can be a distinct difference in constituent levels even between batches from the same supplier.
Pharmaceutical parameters such as flowability and hygroscopicity can vary widely depending on the source of the raw material. Likewise, compactability varies widely and all these factors may affect tablet/capsule weights and, therefore, levels of activity [21] .
The species present in a herbal product is an appropriate indicator of quality as different species can have different clinical efficacies. If the products have species that are different from those stated on the label, the levels of Quality of herbal medicinal products Natural Product Communications Vol. 6 (5) 2011 741 marker may deviate from the standard, and the product may be ineffective for the uses for which it is indicated, or alternatively may be toxic.
Investigation for contaminants
Herbal products can also be contaminated with adulterants, which can occur naturally from raw materials that are carried through the manufacturing process. Adulterants are not often used as a chemical marker for quality because these compounds are often only analyzed when a patient suffers a reaction. Many manufacturers in the EU try to regulate the manufacturing process to avoid such contamination. However, the same quality cannot be guaranteed by international manufacturers [56] . A number of researchers have applied markers of contaminants in an attempt to ensure that herbal products are non-toxic, safe and prevent harm to the consumers.
Aloe vera:
The main active constituents of pharmaceutical grade Aloes are hydroxyanthracene derivatives. Aloin, one of the derivatives responsible for the pharmaceutical use of aloe as a laxative, can cause serious adverse effects with chronic and excessive use. These compounds should not be present in Aloe vera products. Due to the problems associated with aloin, Bozzi et al. and Lachenmeir et al. investigated the aloin content, which has a maximum limit imposed by the EU of 0.1mg/kg in all foods and beverages [57, 58] . Bozzi et al. used HPLC-UV to separate "aloin type" compounds and 1 H NMR spectroscopy to assess the authenticity and quality of the product by identifying the presence of organic acids (see below). HPLC-UV is an effective method to quantify the aloin content, and 1 H NMR spectroscopy is suitable for qualitative analysis. No aloin was detected in three products, and five products had aloin levels below 0.1 mg/ kg. Two products had the correct amount of organic acids and there was insufficient material available to determine the aloin content in one of these products [57] .
A. vera products can also contain organic acids, including lactic acid and succinic acid. These organic acids cause enzyme degradation of the product, and the maximum content allowed is 10% w/w. Citric acid is a naturally occurring preservative and can be added to prevent oxidation, but the upper limit for this compound is 10 g/100 g. Bozzi et al. also investigated the quantities of organic acids in A. vera products [57] .
Lachenmeir et al. used high performance thin layer chromatography (HPTLC), GC-MS and HPLC for analysis of the markers. HPTLC was used to confirm the authenticity of the products, GC-MS to confirm the identity of constituents, and HPLC to confirm the presence of some preservatives and aloin. One beverage contained aloin above the legal limit of 0.1 mg/L. Preservatives are prohibited in herbal products by the EU, and of the products investigated, seventeen tested positive for preservatives [58] .
Bilberry: Penman et al. analyzed two commercially available bilberry extracts using the simple spectrophotometric method of the British Pharmacopoeia, and the assay indicated 24% of anthocyanins in total. Reanalysis using an HPLC assay with photodiode array detection revealed an anthocyanin content of 9% and the presence of amaranth dye, which was confirmed by NMR spectroscopy [59] .
Echinacea: Li et al. investigated the contamination of commercial Echinacea products with colchicine due to a previous report that had reported colchicine contamination in many dietary supplements [60] . Colchicine poisoning is rare but can be fatal in doses exceeding 0.8 mg/kg. LC-MS-MS was used to detect and quantify the presence of colchicine. This method was shown to be suitable for quantitative analysis and suitable as an alternative to HPLC-UV, if herbal compounds are non-chromophoric.
Aristolochic acids: Aristolochic acids AAI and AAII are associated with severe nephrotoxicity and urothelial cancer in humans. Aristolochic acid containing herbs have been variously banned in numerous countries. Using HPLC, a number of Chinese herbs and manufactured products purchased in Australia were found to contain these contaminants after the ban. This problem was probably caused by confusion in botanical identification and imprecise labelling [61] .
Phytoestrogens: Grippo et al. investigated the possible presence of flavonoid phytoestrogens in samples of Ephedra commercial products using HPLC. All products were shown to contain one or more of the flavonoids biochanin A, daidzein, formononetin, genistein and quercetin, while one contained four of them. Levels were such that a daily dose of up to 22 mg/day would occur at normal dosage levels, which may result in health problems. Seven further herbal products were surveyed and Echinacea, Kava, Saw palmetto and Valerian were also found to contain one or more of these phytoestrogens [62] .
Products of high quality
The overall quality of the herbal product is dependant on the quality and quantity of the marker. Most reports used a suitable method to determine the actual content of the marker. A large number of products in this study did not meet the quality criteria due to the marker content being either too high or too low, and in some cases because the species used was different.
There are many reasons for which the quality was deemed to be poor. Many authors used the currently claimed active constituent(s) as a marker. The marker(s) can be affected at any point from cultivation to the final product. The amount of these markers can vary due to the growth environment, the plant part used, the time of harvesting 742 Natural Product Communications Vol. 6 (5) 2011
Ruparel & Lockwood and/or the manufacturing processes [39] . A number of examples are documented.
Echinacea plants that are harvested too early have been shown to contain lower levels of cichoric acid than mature plants [11] . During the growth season, the flavonol glycoside and terpene lactone content in Ginkgo biloba leaves has been shown to decrease and increase, alternately [63] . Variations in active constituents can also occur depending on the source of the plant. The parthenolide content of feverfew varies depending on geographical origin, and has been found to be higher in plants grown in Germany than in those grown in Mexico [19] .
During the manufacturing process, the water content of herbal plants is often reduced to aid storage and transportation. Sokhansanj et al. showed that drying of Panax quinquefolius affects the physical quality of the plant and also decreases the ginsenoside content [64] . Bozzi et al. also found that improper manufacturing processes can cause chemical degradation, which reduces the quality of the product [57] .
The choice of the marker used for quality assessment must be appropriate for the product. Cui et al. determined the actual content of three specific ginsenosides to establish the product quality [33] . As there are more than three types of ginsenosides and the label did not specify the particular ginsenosides used, the actual content calculated may be incorrect. However, Harkey et al. [33] and Krochmal et al. [13] successfully used ginsenosides as a marker to differentiate the species used for formulating a product.
The data collated have shown that there is a great variation in the quality of herbal products due to multiple factors. Unlike conventional medicines, some herbal products investigated are known to contain more than one active constituent, but not all of them were assessed. Some reviews only investigated the type of plant species present in a product, but did not assess the level of active constituents. Some products were found to match the label claim and deemed to be of good quality.
The quality of herbal products cannot be determined from only analyzing a specific marker and comparing this to the product label claim. To determine the true quality of herbal products, ideally all the contents of the product need to be analyzed. Further investigations should involve analysis of all the components within a product to determine the quality.
Many of these herbal products are known to contain a large range of related constituents, possibly responsible either individually or collectively for any claimed activity. Reliance on chemical estimation of individual components, as is currently being carried out, gives an indication of possible activity, but the only true estimate of activity should ideally involve in vitro or in vivo assessment. Thoroughly standardized products may then provide reliable activity.
Conclusion
Although this review covers a wide range of published data, information about complex mixtures of constituents in a number of products is still unavailable, as are data on further uninvestigated plant formulations. Ensuring the quality of herbal products is a process which requires quality control and quality assurance from the moment of cultivation to the final product. There are many pre-and post harvesting processes and manufacturing factors which can affect the level of active constituent(s) within a plant. Currently, manufacturers of these investigated products are not required to take these factors into account when producing the final product.
However, since the introduction of the THMPD, manufacturers are required to consider these factors to ensure that the quality of herbal products will be the same as conventional medicines. In addition, many herbal products have a Traditional Herbal Registration or manufacturing authorization. This standardization of herbal products may eliminate the concerns associated with quality of herbal products and ensure their safety to consumers. In addition, if products have been registered with the THMRS, then all future products should have little or no batch-to-batch and manufacturer-to-manufacturer variations.
The significance of determining the quality of herbal products has become more important as their use has greatly increased. To ensure these products are effective and do not cause toxic or harmful effects, it is essential that the contents are standardized. The evidence collected about the use of specific markers and the factors which can affect quality of products may help aid further investigations for better use of analytical systems and QC of herbal products.
